Latest Asx Company Filings News

Page 40 of 713
SDI Limited reported a modest 2% dip in net profit for H1 FY26 despite a 2.7% rise in sales, driven by growth in aesthetics and exports. The company faces challenges from regulatory bans on Amalgam products while advancing plans for manufacturing upgrades and a potential acquisition.
Ada Torres
Ada Torres
27 Feb 2026
Michael Hill International reported a 3% rise in group sales and a 28.6% jump in comparable EBIT for the half-year ended December 2025, driven by strong performances across Australia, Canada, and New Zealand. Despite improved earnings and cash flow, the board has opted to withhold an interim dividend, signalling cautious optimism.
Logan Eniac
Logan Eniac
27 Feb 2026
Pointerra Limited reported a $2.14 million loss for the half-year ending December 2025 amid a 51% revenue decline, yet the company highlights promising contract wins and a growing recurring revenue base that could drive a turnaround in the second half.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.
Ada Torres
Ada Torres
27 Feb 2026
Murray Cod Australia Ltd reported a 40% revenue increase to $6.69 million for H1 2026 but swung to a $4.06 million net loss, reflecting significant investments and operational expansion.
Ada Torres
Ada Torres
27 Feb 2026
Epsilon Healthcare Limited has reported a robust recovery in 2025, with revenue climbing 68% to $9.39 million and net losses shrinking by 63%, driven by growth in contract manufacturing and a new pharmacy division.
Ada Torres
Ada Torres
27 Feb 2026
Aumake Limited reported a sharp 45% drop in half-year revenue alongside a 24% increase in net loss, while securing new capital and a major distribution deal to support its pivot in the China market.
Logan Eniac
Logan Eniac
27 Feb 2026
Advanced Energy Minerals reports a sharp revenue increase alongside a substantial net loss for 2025, completing a major plant expansion and raising $44.8 million in its IPO.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Avecho Biotechnology reported a 9.3% revenue increase alongside a 41.5% rise in net loss for 2025, while progressing its Phase III CBD insomnia trial and securing a significant licensing agreement with Sandoz.
Ada Torres
Ada Torres
27 Feb 2026
AJ Lucas Group Limited has swung to a $38.9 million half-year profit, buoyed by a significant UK settlement and improved Australian drilling operations despite revenue pressures.
Maxwell Dee
Maxwell Dee
27 Feb 2026
RooLife Group Ltd has reported a 144% surge in half-year revenue to $3.75 million, driven by strong growth in proprietary product sales, notably its RLG Coffee range in China. The company also reduced its net loss by 23%, reflecting operational improvements and strategic divestments.
Victor Sage
Victor Sage
27 Feb 2026
SOCO Corporation reports a 12% revenue drop to $9.7 million for H1 FY26, weighed down by a $4.6 million goodwill impairment linked to AxSym. Despite growth in core consulting, the company posted a significant net loss and undertook restructuring to align costs.
Victor Sage
Victor Sage
27 Feb 2026